Autopsy report · NCT00785967

Immune Responses in Patients Treated With Raltegravir

“Unexpected and severe difficulties in recruitment.”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Phase 3

Sponsor

McGill University Health Centre/Research Institute of the McGill University Health Centre

Sponsor type

University, hospital or other

Conditions

HIV Infections

Interventions

Various vaccines

Participants

0

Sites

1

Countries

Canada

Trials that died the same way

• Efficacy of Angiographic Embolization vs Non-embolization of Moderate/Poor Vascularized Vertebral Metastases on Intraoperative Bleeding During Surgery Decompression and Vertebral Stabilization.
  “Difficulties in recruitment.” (93% match in meaning)
• Abdominal Pain Disorders Functional in Children: Impact of Hypno-analgesia on the Autonomic Balance
  “Recruitment difficulties.” (91% match in meaning)
• The Cirrhosis Outpatient Optimization, Readmission & Safety Study
  “Increased recruitment difficulties” (88% match in meaning)
• Alzheimer Disease : Rehabilitation's Intervention at Home
  “difficulties of recruitment” (88% match in meaning)
• Sensitivity of Frequent SARS-CoV-2 (COVID-19) Rapid Antigen Testing Regimen
  “Difficulty with recruitment.” (87% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.